BLFS
BIOLIFE SOLUTIONS INC
Latest close $33.80 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 6 parsed filing(s) · 3 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported accumulation | 6.5M +1.3M | 13.50% +1.50 pts | $19.08 | $20.76 | $33.80 |
| Invesco CIK0000914208 | Mar 31, 2026 observed May 6, 2026 filed · 36d Schedule 13G amendment | Reported reduction | 2.3M -1.6M | 12.00% 0.00 pts | $19.08 | $21.75 | $33.80 |
| Invesco CIK0000914208 | Dec 31, 2025 observed Feb 12, 2026 filed · 43d Schedule 13G amendment | Reported accumulation | 3.9M +689.8K | 12.00% +5.00 pts | $24.18 | $21.58 | $33.80 |